LDHA-mediated YAP lactylation promotes the tumor progression of hepatocellular carcinoma by inducing YAP dephosphorylation and activation
Abstract Background Hepatocellular carcinoma (HCC) is among the deadliest cancers globally. Yes-Associated Protein (YAP), a Hippo pathway effector, crucially regulates cell proliferation and apoptosis. Recent research has implicated YAP’s role in HCC progression, but the mechanisms are unclear. This...
Saved in:
| Main Authors: | Xiaoyong Wei, Long Zou, Yanqing Huang, Chuan Qiu, Guang Cheng, Ye Chen, Jun Rao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-05-01
|
| Series: | Biology Direct |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13062-025-00655-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Estrogen receptor α suppresses hepatocellular carcinoma by restricting M2 macrophage infiltration through the YAP-CCL2 axis
by: De-Hua Wang, et al.
Published: (2025-03-01) -
PRMT1‐mediated arginine methylation promotes YAP activation and hepatocellular carcinoma proliferation
by: Jian Yu, et al.
Published: (2024-12-01) -
RACGAP1 and MKI67 are potential prognostic biomarker in hepatocellular carcinoma caused by HBV/HCV via lactylation
by: Muhammad Muddasar Saeed, et al.
Published: (2025-05-01) -
The Mechanical Role of YAP/TAZ in the Development of Diabetic Cardiomyopathy
by: Jun-Xian Shen, et al.
Published: (2025-04-01) -
YAP and ECM Stiffness: Key Drivers of Adipocyte Differentiation and Lipid Accumulation
by: Da-Long Dong, et al.
Published: (2024-11-01)